LLY
Eli Lilly and Company
1,183.50$
+0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.5% | -6.3% | +28.9% | +1.2% | +18.3% | -5.9% | +22.2% | +13.1% | +9.6% | +2.6% | +16.0% | – | |
| – | -3.9% | -6.4% | +29.7% | +0.0% | +10.7% | -7.5% | +10.1% | +22.9% | +12.1% | +6.1% | -8.6% | – | |
| – | -1.0% | -6.2% | +28.7% | +1.5% | +20.1% | -5.6% | +24.8% | +11.3% | +9.1% | +1.9% | +21.5% | – | |
| – | +6.4% | -1.6% | +7.5% | +0.8% | +10.5% | -9.6% | +22.0% | +3.9% | +9.7% | -7.7% | +8.8% | – | |
| – | +7.2% | +1.5% | +9.1% | -0.9% | +16.3% | +2.3% | +12.1% | +3.5% | +22.0% | -12.2% | +16.9% | – | |
| – | +6.7% | -0.3% | +8.1% | +0.1% | +13.0% | -4.4% | +17.4% | +3.7% | +11.7% | -7.1% | +12.5% | – | |
| – | -9.8% | -14.3% | +61.5% | +3.0% | +27.4% | -6.7% | +31.8% | +17.7% | +7.2% | +8.8% | +27.4% | – | |
| – | +10.9% | +30.0% | +2.2% | +5.0% | +16.6% | +8.5% | +2.2% | -27.9% | -31.5% | +169.9% | +3.9% | – | |
| – | +487.3% | +1.1% | +38.7% | -54.8% | +217.2% | -31.4% | +96.1% | +6.7% | +14.3% | +7.1% | +4.5% | – | |
| – | -34.2% | -8.1% | +87.7% | +12.3% | +1.7% | +10.8% | +60.1% | +47.9% | -1.3% | -10.7% | +48.0% | – | |
| – | – | +2.4% | +32.3% | -67.3% | +354.5% | -37.4% | +105.1% | -1.4% | +18.9% | +11.4% | -4.1% | – | |
| – | +215.2% | +2.7% | +32.1% | -45.4% | +155.7% | -27.6% | +80.3% | +5.0% | +54.1% | -15.3% | +26.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.